Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIB-IMRT with or without Concurrent Chemotherapy for Esophageal Cancer
NCT03328234Phase 3Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Sep 2017
- Primary completion
- Aug 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, cisplatin, nedaplatin, lobaplatin in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
paclitaxelcisplatinnedaplatinlobaplatin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT03328234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03328234.